These two pharma heavyweights are among the many players racing to get a COVID-19 vaccine approved.
News & Analysis: AstraZeneca
Looking for big yield at a discount? These three could fit the bill.
Just the facts, Fool.
Look here for a clue.
Randgold Resources, RSA Insurance, and AstraZeneca have previously been three of the shares most unaffected by extreme market moves. They are what market statisticians call "low beta" shares.
A structured analysis of AstraZeneca.
How might earnings at AstraZeneca change in the years to come?
AstraZeneca announces the purchase of an American developer of asthma treatments.
How do AstraZeneca's growth prospects stack up?